Compounds > cysteine

cysteine and Ovarian Neoplasms

cysteine has been researched along with Ovarian Neoplasms in 27 studies

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (7.41)18.2507
2000's5 (18.52)29.6817
2010's15 (55.56)24.3611
2020's5 (18.52)2.80

Authors

AuthorsStudies
Fang, CY; Lei, MZ; Lei, QY; Li, JT; Li, KY; Lu, HJ; Pei, X; Qu, J; Shen, Y; Wen, W; Yang, HJ; Yin, M1
Chen, J; Chen, M; Huang, X; Liu, J; Shangguan, M; Wang, T; Wu, S; Yang, Z; Zhang, C; Zhao, S1
Burgos-Morón, E; Calderón-Montaño, JM; Díaz-Ortega, P; Guillén-Mancina, E; Jiménez-Alonso, JJ; Jiménez-González, V; López-Lázaro, M1
Binte Idres, S; Dai, MZ; Damen, JMA; Deng, LW; Huang, RY; Lee, ZW; Long, YC; Nin, DS; Novera, W; Sim, AYL; Tan, TZ; Wu, H; Wu, W1
Abidi, A; Beriou, G; Dilek, N; Gueno, L; Lancien, M; Louvet, C; Merieau, E; Michielin, O; Nguyen, TH; Poschmann, J; Salle, S; Solomon, P; Vanhove, B; Vuillefroy de Silly, R1
Lin, N; Ma, S; Su, D; Wu, K; Xu, Y; Yuan, Q; Zhang, S; Zhu, L1
Gouveia-Fernandes, S; Lopes-Coelho, F; Nunes, SC; Pereira, SA; Ramos, C; Serpa, J1
Abreu, S; Brito, C; Félix, A; Gouveia-Fernandes, S; Guimarães, A; Lopes-Coelho, F; Nunes, SC; Pereira, SA; Ramos, C; Rodrigues, A; Santo, VE; Sequeira, CO; Serpa, J; Silva, F; Silveira, M1
Nunes, SC; Serpa, J1
Chaudhuri, G; Janzen, C; Kawahara, B; Mascharak, PK; Ramadoss, S; Sen, S1
Arnaudo, N; Barford, D; Busch, M; Carroll, KS; Garcia, FJ; Komander, D; Kulathu, Y; Mevissen, TE1
Feng, JG; Lin, NM; Luo, M; Su, D; Xu, YS; Zhang, B; Zhang, D1
Chen, H; Jiang, S; Qu, X; Wong, Y; Wu, J; Zhang, F; Zhang, J; Zhao, S; Zhong, Z1
Abate-Pella, D; Blank, DA; Distefano, MD; Goff, PC; Mahmoodi, MM; Palsuledesai, CC; Pundsack, TJ1
Chambers, SK; Howison, CM; Jones, KM; Kobayashi, H; Pagel, MD; Randtke, EA; Sinharay, S1
Bhakta, S; Chen, Y; Clark, S; Dennis, MS; Duenas, E; Flagella, K; Gorrell, J; Junutula, JR; Katta, V; Kim, A; Lee Wong, W; Lee, CC; Leipold, DD; Lowman, HB; Lu, Y; Mallet, W; McDorman, K; Meng, YG; Ng, C; Polakis, P; Raab, H; Ross, S; Scheller, RH; Simpson, M; Sliwkowski, MX; Spencer, SD; Tsai, SP; Vandlen, R; Venook, R; Weir, S; Yang, J1
Bowers, RR; He, L; Hutchens, S; Manevich, Y; Tew, KD; Townsend, DM; Xiong, Y1
Brenton, JD; Cooke, SL; Gilks, CB; Gorbatcheva, B; Heravi-Moussavi, A; Huntsman, DG; Leung, P; Maines-Bandiera, S; Melnyk, N; Monahan, J; Salamanca, C; Schrader, KA; Senz, J1
Benayoun, BA; Caburet, S; D'Haene, B; De Baere, E; Dipietromaria, A; Fellous, M; Georges, A; Krishnaswamy, S; L'Hôte, D; Pandaranayaka, PJ; Todeschini, AL; Veitia, RA1
Appel, E; Kohen, F; Mirelman, D; Neeman, M; Rabinkov, A1
Clarke, CH; Fung, E; Lomas, L; Thulasiraman, V1
Amerik, AY; Issaenko, OA1
Butkevich, AN; Debnath, B; Duncan, R; Neamati, N; Petasis, NA; Xu, S; Yamada, R; Zandi, E; Zhou, Y1
Baek, WK; Cha, SD; Cho, CH; Cho, JW; Kim, SP; Kwon, TK; Park, JW; Suh, MH; Suh, SI; Yeo, JK1
Heikkinen, K; Karppinen, SM; Rapakko, K; Winqvist, R1
Baird, A; Lappi, DA; Martineau, D; Matsunami, R1
Boiocchi, M; Corona, G; Donada, C; Fabris, M; Toffoli, G; Viel, A; Zarrelli, A1

Reviews

1 review(s) available for cysteine and Ovarian Neoplasms

ArticleYear
Glutathione in Ovarian Cancer: A Double-Edged Sword.
    International journal of molecular sciences, 2018, Jun-26, Volume: 19, Issue:7

    Topics: Antioxidants; Cysteine; Drug Resistance, Neoplasm; Female; Glutathione; Humans; Models, Biological; Ovarian Neoplasms

2018

Other Studies

26 other study(ies) available for cysteine and Ovarian Neoplasms

ArticleYear
Palmitoylation of MDH2 by ZDHHC18 activates mitochondrial respiration and accelerates ovarian cancer growth.
    Science China. Life sciences, 2022, Volume: 65, Issue:10

    Topics: Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cysteine; Female; Glutamine; Humans; Lipoylation; Malate Dehydrogenase; Ovarian Neoplasms; Respiration; Tricarboxylic Acids

2022
Gomisin A enhances the antitumor effect of paclitaxel by suppressing oxidative stress in ovarian cancer.
    Oncology reports, 2022, Volume: 48, Issue:5

    Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Complex Mixtures; Cyclin B1; Cyclin-Dependent Kinase 4; Cyclooctanes; Cysteine; Dioxoles; Eosine Yellowish-(YS); Female; Humans; Lignans; Mice; Ovarian Neoplasms; Oxidative Stress; Paclitaxel; Reactive Oxygen Species

2022
Artificial Diets with Altered Levels of Sulfur Amino Acids Induce Anticancer Activity in Mice with Metastatic Colon Cancer, Ovarian Cancer and Renal Cell Carcinoma.
    International journal of molecular sciences, 2023, Feb-27, Volume: 24, Issue:5

    Topics: Amino Acids, Sulfur; Animals; Carcinoma, Renal Cell; Caseins; Colonic Neoplasms; Cysteine; Diet; Female; Humans; Kidney Neoplasms; Leucine; Lipids; Methionine; Mice; Mice, Inbred C57BL; Ovarian Neoplasms; Racemethionine; Taurine

2023
Cysteine Deprivation Targets Ovarian Clear Cell Carcinoma
    Antioxidants & redox signaling, 2020, 12-10, Volume: 33, Issue:17

    Topics: Adenocarcinoma, Clear Cell; Apoptosis; Cell Survival; Cysteine; Female; Ferroptosis; Glutathione; Humans; Iron; Mitochondria; Models, Biological; Necrosis; Ovarian Neoplasms; Oxidative Stress; Sulfur

2020
Cystathionine-gamma-lyase overexpression in T cells enhances antitumor effect independently of cysteine autonomy.
    Cancer science, 2021, Volume: 112, Issue:5

    Topics: Adoptive Transfer; Animals; CD8-Positive T-Lymphocytes; Cell Engineering; Cell Line, Tumor; Cell Proliferation; Cystathionine gamma-Lyase; Cysteine; Extracellular Fluid; Female; Glycine; Methionine; Mice; Mice, Inbred C57BL; Models, Animal; Ovarian Neoplasms; Proline; Serine; Tumor Microenvironment

2021
S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1.
    Journal of ovarian research, 2018, May-14, Volume: 11, Issue:1

    Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cysteine; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Ovarian Neoplasms

2018
Cysteine boosters the evolutionary adaptation to CoCl
    BMC evolutionary biology, 2018, 06-19, Volume: 18, Issue:1

    Topics: Adaptation, Physiological; Biological Evolution; Carboplatin; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cobalt; Cysteine; Drug Resistance, Neoplasm; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Ovarian Neoplasms

2018
Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity.
    Scientific reports, 2018, 06-22, Volume: 8, Issue:1

    Topics: Adaptation, Physiological; Ascitic Fluid; Carboplatin; Cell Line, Tumor; Cell Survival; Cysteine; Dose-Response Relationship, Drug; Female; Humans; Intracellular Space; Neoplastic Stem Cells; Ovarian Neoplasms; Tumor Hypoxia

2018
Carbon monoxide sensitizes cisplatin-resistant ovarian cancer cell lines toward cisplatin via attenuation of levels of glutathione and nuclear metallothionein.
    Journal of inorganic biochemistry, 2019, Volume: 191

    Topics: Antineoplastic Agents; Carbon Monoxide; Cell Line, Tumor; Cell Nucleus; Cisplatin; Cystathionine beta-Synthase; Cysteine; Drug Resistance, Neoplasm; Female; Glutathione; Humans; Metallothionein; Ovarian Neoplasms

2019
Regulation of A20 and other OTU deubiquitinases by reversible oxidation.
    Nature communications, 2013, Volume: 4

    Topics: Amino Acid Sequence; Biocatalysis; Crystallography, X-Ray; Cysteine; DNA-Binding Proteins; Endopeptidases; Enzyme Activation; Female; Humans; Intracellular Signaling Peptides and Proteins; Molecular Sequence Data; Nuclear Proteins; Ovarian Neoplasms; Oxidation-Reduction; Protein Structure, Tertiary; Reducing Agents; Sulfenic Acids; Tumor Necrosis Factor alpha-Induced Protein 3

2013
S-allylcysteine, a garlic derivative, suppresses proliferation and induces apoptosis in human ovarian cancer cells in vitro.
    Acta pharmacologica Sinica, 2014, Volume: 35, Issue:2

    Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cysteine; Female; Garlic; Humans; Ovarian Neoplasms

2014
Over-expression of survivin is a factor responsible for differential responses of ovarian cancer cells to S-allylmercaptocysteine (SAMC).
    Experimental and molecular pathology, 2016, Volume: 100, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cadherins; Caspase 3; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cysteine; Female; Garlic; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Integrin beta1; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Survivin; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays

2016
Nitrodibenzofuran: A One- and Two-Photon Sensitive Protecting Group That Is Superior to Brominated Hydroxycoumarin for Thiol Caging in Peptides.
    Journal of the American Chemical Society, 2016, 05-11, Volume: 138, Issue:18

    Topics: Antineoplastic Agents; Benzofurans; Cell Line, Tumor; Cell Membrane; Coumarins; Cysteine; Cytosol; Farnesyl-Diphosphate Farnesyltransferase; Female; Golgi Apparatus; Halogenation; Humans; Indicators and Reagents; Ovarian Neoplasms; Peptides; Photochemical Processes; Photons; Solid-Phase Synthesis Techniques; Sulfhydryl Compounds

2016
Noninvasive detection of enzyme activity in tumor models of human ovarian cancer using catalyCEST MRI.
    Magnetic resonance in medicine, 2017, Volume: 77, Issue:5

    Topics: Animals; Catalysis; Cell Line, Tumor; Contrast Media; Cysteine; Disease Models, Animal; Female; Fluorescent Dyes; gamma-Glutamyltransferase; Glycine; Humans; Hydrogen-Ion Concentration; Image Processing, Computer-Assisted; Kinetics; Magnetic Resonance Imaging; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Peptides

2017
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index.
    Nature biotechnology, 2008, Volume: 26, Issue:8

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antibody Specificity; Antineoplastic Agents; Binding Sites; CA-125 Antigen; Cell Line, Tumor; Chemistry, Pharmaceutical; Cysteine; Cytotoxins; Female; Humans; Immunotoxins; Macaca fascicularis; Membrane Proteins; Mice; Mutagenesis, Site-Directed; Oligopeptides; Ovarian Neoplasms; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds

2008
Nitrosative stress-induced s-glutathionylation of protein disulfide isomerase leads to activation of the unfolded protein response.
    Cancer research, 2009, Oct-01, Volume: 69, Issue:19

    Topics: 4-Aminobenzoic Acid; Amino Acid Sequence; Azo Compounds; Catalytic Domain; Cell Line, Tumor; Cysteine; Female; Glutathione; HL-60 Cells; Humans; Models, Molecular; Molecular Sequence Data; Neoplasms; Nitric Oxide; Ovarian Neoplasms; para-Aminobenzoates; Protein Disulfide-Isomerases; Protein Folding; Proteomics; Structure-Activity Relationship

2009
The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors.
    PloS one, 2009, Nov-24, Volume: 4, Issue:11

    Topics: Alleles; Cell Line, Tumor; Cysteine; Cytogenetics; Female; Forkhead Box Protein L2; Forkhead Transcription Factors; Genomics; Granulosa Cell Tumor; Humans; In Situ Hybridization, Fluorescence; Karyotyping; Mutation; Ovarian Neoplasms; Tissue Distribution; Tryptophan

2009
Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G).
    PloS one, 2010, Jan-20, Volume: 5, Issue:1

    Topics: Adult; Amino Acid Sequence; Cell Line, Tumor; Cysteine; Female; Forkhead Box Protein L2; Forkhead Transcription Factors; Granulosa Cell Tumor; Humans; Models, Molecular; Molecular Sequence Data; Mutation; Open Reading Frames; Ovarian Neoplasms; Subcellular Fractions; Transcriptional Activation; Tryptophan

2010
Conjugates of daidzein-alliinase as a targeted pro-drug enzyme system against ovarian carcinoma.
    Journal of drug targeting, 2011, Volume: 19, Issue:5

    Topics: Animals; Antineoplastic Agents; Carbon-Sulfur Lyases; Cell Line, Tumor; Cell Survival; Cysteine; Drug Compounding; Female; Fluorescent Dyes; Humans; Isoflavones; Luciferases; Mice; Mice, Nude; Molecular Imaging; Ovarian Neoplasms; Prodrugs; Tissue Distribution; Transfection; Treatment Outcome; Xenograft Model Antitumor Assays

2011
Optimized conditions for a quantitative SELDI TOF MS protein assay.
    Methods in molecular biology (Clifton, N.J.), 2012, Volume: 818

    Topics: Artifacts; Biomarkers, Tumor; Blood Chemical Analysis; Calibration; Cysteine; Female; Humans; Ovarian Neoplasms; Prealbumin; Protein Array Analysis; Protein Isoforms; Reference Standards; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2012
Chalcone-based small-molecule inhibitors attenuate malignant phenotype via targeting deubiquitinating enzymes.
    Cell cycle (Georgetown, Tex.), 2012, 05-01, Volume: 11, Issue:9

    Topics: Antineoplastic Agents; Apoptosis; Benzylidene Compounds; Boronic Acids; Bortezomib; Breast Neoplasms; Catalytic Domain; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Chalcone; Cyclin D1; Cysteine; Dose-Response Relationship, Drug; Endopeptidases; Female; HeLa Cells; Humans; Ovarian Neoplasms; Phenotype; Piperidones; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines; Tumor Suppressor Protein p53; Ubiquitin Thiolesterase; Ubiquitins

2012
Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment.
    Proceedings of the National Academy of Sciences of the United States of America, 2012, Oct-02, Volume: 109, Issue:40

    Topics: Alkynes; Amino Acid Sequence; Animals; Binding Sites; Blotting, Western; Cell Line, Tumor; Cell Survival; Chromatography, Liquid; Cysteine; Dipeptides; Drug Discovery; Electrophoresis, Gel, Two-Dimensional; Female; Histological Techniques; Humans; Immunoprecipitation; Mice; Mice, Nude; Microscopy, Fluorescence; Molecular Sequence Data; Molecular Structure; Ovarian Neoplasms; Propionates; Protein Disulfide-Isomerases; Tandem Mass Spectrometry; Thiophenes

2012
Se-methylselenocysteine induces apoptosis through caspase activation and Bax cleavage mediated by calpain in SKOV-3 ovarian cancer cells.
    Cancer letters, 2002, Aug-08, Volume: 182, Issue:1

    Topics: Anticarcinogenic Agents; Apoptosis; bcl-2-Associated X Protein; Calpain; Caspases; Cysteine; Cytochrome c Group; Enzyme Activation; Female; Humans; Inhibitor of Apoptosis Proteins; Organoselenium Compounds; Ovarian Neoplasms; Poly(ADP-ribose) Polymerases; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Selenocysteine; Tumor Cells, Cultured

2002
Mutation screening of the BARD1 gene: evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer.
    Journal of medical genetics, 2004, Volume: 41, Issue:9

    Topics: Alleles; Amino Acid Sequence; Breast Neoplasms; Cysteine; DNA Mutational Analysis; Female; Finland; Genetic Predisposition to Disease; Genetic Testing; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation; Ovarian Neoplasms; Pedigree; Serine; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases

2004
Reducing the heterogeneity of chemically conjugated targeted toxins: homogeneous basic FGF-saporin.
    Analytical biochemistry, 1993, Aug-01, Volume: 212, Issue:2

    Topics: 3T3 Cells; Animals; Base Sequence; Blotting, Western; Cysteine; Female; Fibroblast Growth Factor 2; Humans; Immunotoxins; Melanoma, Experimental; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; N-Glycosyl Hydrolases; Ovarian Neoplasms; Plant Proteins; Receptors, Fibroblast Growth Factor; Ribosome Inactivating Proteins, Type 1; Saporins; Serine; Tumor Cells, Cultured

1993
Homocysteine accumulation in human ovarian carcinoma ascitic/cystic fluids possibly caused by metabolic alteration of the methionine cycle in ovarian carcinoma cells.
    European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:8

    Topics: Adult; Aged; Ascitic Fluid; Cysteine; Female; Folic Acid; Glycine; Homocysteine; Humans; Methionine; Methylation; Middle Aged; Ovarian Neoplasms; Vitamin B 12

1997